Conavi Medical Corp. (CNVI : TSX-V)
Common Stock
$0.23
CAD
+0.01 (4.55%)
Last updated: 2026-07-02
CNVI
Conavi Medical Corp.
WealthAwesomePerformance
1 Day
+4.55%
1 Week
-3.16%
1 Month
-20.69%
YTD
-47.73%
Key Statistics
Market Cap
$23.80M
52W High
$0.70
52W Low
$0.22
P/E Ratio
-
50 Day MA
$0.30
200 Day MA
$0.44
Beta
-
Dividend Yield
-
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 7/2/2026 | $0.23 | $0.23 | $0.23 | $0.23 | $0.23 | 4,484 |
| 6/30/2026 | $0.23 | $0.23 | $0.22 | $0.22 | $0.22 | 132,281 |
| 6/29/2026 | $0.25 | $0.26 | $0.25 | $0.26 | $0.26 | 9,092 |
| 6/26/2026 | $0.25 | $0.25 | $0.24 | $0.24 | $0.24 | 1,115 |
| 6/25/2026 | $0.26 | $0.26 | $0.23 | $0.24 | $0.24 | 19,715 |
| 6/24/2026 | $0.24 | $0.24 | $0.24 | $0.24 | $0.24 | 11,062 |
| 6/23/2026 | $0.23 | $0.23 | $0.23 | $0.23 | $0.23 | 2,100 |
| 6/22/2026 | $0.24 | $0.24 | $0.23 | $0.23 | $0.23 | 21,647 |
| 6/19/2026 | $0.23 | $0.23 | $0.23 | $0.23 | $0.23 | 1,550 |
| 6/18/2026 | $0.24 | $0.24 | $0.23 | $0.23 | $0.23 | 33,128 |
Analyst Price Targets
Based on analyst covering CNVI
Wall Street analysts forecast CNVI stock price to rise 334.8% over the next 12 months.
Consensus
No RatingAvg. Target
C$1.00
+334.8% Upside
Current Price
C$0.23
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on CNVI's historical volatility
30-Day Vol
96.2%
Annualized
90-Day Vol
80.2%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$0.19
Expected price
| Horizon | Expected | 68% Range (1ฯ) |
|---|---|---|
| 30 trading days | C$0.22 | C$0.16 โ C$0.30 |
| 60 trading days | C$0.20 | C$0.13 โ C$0.33 |
| 90 trading days | C$0.19 | C$0.11 โ C$0.34 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ยฑ1ฯ, 95% band = ยฑ2ฯ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About Conavi Medical Corp.
Conavi Medical Corp. focuses on designing, manufacturing, and marketing imaging technologies to guide common minimally invasive cardiovascular procedures. It offers Novasight Hybrid System, a system that combines intravascular ultrasound and optical coherence tomography to enable simultaneous and co-registered imaging of coronary arteries. Conavi Medical Corp. is based in Toronto, Canada.
Financials
- Revenue (TTM)
- $778,000
- EBITDA
- $-19.01M
- Profit Margin
- 0.00%
- ROE (TTM)
- 0.00%
- EPS (Diluted)
- -0.20
- Book Value
- -0.14
Advertisement
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE ReportExplore More
Common Questions About CNVI
Articles Featuring CNVI.V
Latest articles and analysis covering CNVI.V
Why Conavi Medical Corp. stock is plummeting today
Conavi Medical Corp. (CNVI.V) has faced a sharp decline of 13.73% in its stock price today, closing at CA$0.22. This downturn reflects investor concerns over the company's financial stability and its recent capital-raising efforts.
Why Conavi Medical Corp. stock is rising today
Conavi Medical Corp. (CNVI.V) has seen a 4.08% increase in its stock price following a successful public offering and positive fiscal results, signaling potential growth in the medical technology sector.
Why Conavi Medical Corp. stock is skyrocketing today
Conavi Medical Corp. is enjoying a notable rise in its stock price today, driven by investor optimism about its future prospects and product developments.
Why Conavi Medical Corp. stock is rising today
Conavi Medical Corp. has seen a rise in its stock price, buoyed by strategic developments and a growing interest among investors as it prepares for a potential U.S. market entry.
